Proteostasis Therapeutics, Inc. Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Proteostasis Therapeutics (PTI) IPO Opens Flat
February 11, 2016 10:27 AM ESTToday's IPO for Proteostasis Therapeutics (NYSE: PTI) opened for trading at $8 after pricing 6,250,000 shares of common stock at a public offering price of $8.00 per share, before underwriting discounts and commissions. The company had planned to offer 3,850,000 shares at $12-$14.
Leerink Partners and RBC... More
Proteostasis Therapeutics (PTI) Prices Upsized IPO at $8, Well Below Plan
February 11, 2016 8:26 AM ESTProteostasis Therapeutics, Inc. (NYSE: PTI) announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $8.00 per share, before underwriting discounts and commissions. The company had planned to offer 3,850,000 shares at $12-$14. Shares are expected to... More
